IMNM (Immunome Inc) Sof foyda

IMNM (Immunome) - kompaniyaning tovar belgisi

Immunome, Inc. (IMNM) yangi o'sma antitanachalarini aniqlash uchun organizmning o'z himoya mexanizmlaridan foydalanib, sanoat yetakchilari bilan uzoq muddatli hamkorlik uchun asos solmoqda. Kompaniya hozirda maqsadli terapiya portfelini kengaytirish va birlamchi molekulalarni sinovdan o'tkazishni tezlashtirishga e'tibor qaratmoqda. Robotlashtirilgan B-hujayralar tahlil stansiyalarining joriy etilishi rutinda bajariladigan mehnatni bartaraf etadi, foyda ko'rsatkichi esa -0.25 darajasida turibdi. GURU.Markets grafigidagi tasdiqlangan narxlar tarixi ushbu jarayonlarni aniq vizuallashtiradi.

IMNM (Immunome, Inc.) Sof foyda tarixi 04.07.2022dan 31.10.2026gacha

Immunome (IMNM) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Immunome Bio|IMNM - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Immunome Bio|IMNM - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Immunome|IMNM - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi immunome.com|IMNM - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Immunome, Inc.|IMNM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Immunome Inc|IMNM - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Immunome Bio|IMNM - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Immunome|Shoshilinch likvidlik immunome.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
IMNM - Sof foyda
Kompaniyaning jamlanma tahlili:Immunome, Inc.
Immunome Corp asosiy tovari

Immunome, Inc. (IMNM) faoliyatining ko'lami maqsadli dori vositalari va radioligandlarni ishlab chiqish intensivligi bilan belgilanadi. Ushbu ko'rsatkich mablag'larning kunlik kirimini qamrab oladi va makroiqtisodiyotning moliyaviy natijaga ta'sirini zudlik bilan aks ettiradi. Metrika vaqtincha hisobotdagi tafovutlarni istisno qilgan holda, real operatsion foydani o'lchaydi. R&D kompaniyalari uchun bunday narx harakati klinik pipeline samaradorligini tasdiqlaydi. Kompaniyaning sof foydasini tahlil qilish orqali investor aktivni cho'qqisida sotib olayotganda haddan tashqari ko'p to'lash xavfini baholashi mumkin.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Sof moliyaviy natija Pharming Corp PHAR|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|Sof daromad upstreambio.com|Kompaniyaning sof foydasi Zenas Biopharma|Sof daromad Gossamer Bio Inc (GOSS)|Sof daromad KALV (KalVista Pharmaceuticals Inc)|Sof foyda Septerna Pharma (SEPN)|Kompaniyaning sof foydasi Pieris Pharmaceuticals PVLA|SVRA: Kompaniya foydasi|RIGL - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi AnaptysBio Inc|Astria Pharma (ATXS) - Kompaniyaning sof foydasi|Sof daromad enGene Corp|RAPT (RAPT Therapeutics, Inc.) - Sof foyda|Kompaniyaning sof daromadi Aerovate JBIO|Sof daromad ACRS (Aclaris Therapeutics, Inc.)|KYTX (Kyverna Therapeutics Inc.) - Yakuniy foyda|Sof foyda TLSA (Tiziana Life Sciences PLC)|Sof moliyaviy natija Cabaletta Bio Inc (CABA)|VTYX - Kompaniyaning sof foydasi|THTX (theratech.com) - Kompaniya foydasi|AVTX: Sof foyda|Sof daromad Eledon Pharmaceuticals Inc.|Sof daromad AGEN|Climb Bio, Inc (CLYM) - Sof moliyaviy natija|Sof foyda ZURA|Sof moliyaviy natija atyrpharma.com|Kompaniyaning sof foydasi Adagene Inc. ADAG|IMA - Sof daromad|STTK - Kompaniyaning sof foydasi|EQ (Equillium, Inc.) - Kompaniya foydasi|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|Sof daromad Immunic|Kompaniyaning sof foydasi Atara Biotherapeutics, Inc.|InflaRx GmbH - Soliqdan keyingi foyda|Sof foyda XFOR|ACET (adicetbio.com) - Yakuniy foyda|Sof foyda CELU (Celularity)|Sof foyda inmunebio.com INMB|BRNS - Kompaniyaning sof foydasi|Yakuniy foyda KZR (Kezar Life Sciences Inc.)|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|Sof daromad Akari Therapeutics, Plc|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|Sof foyda Q32 Bio Corp|Sof daromad GOVX (GeoVax)|EDSA (Edesa Biotech Inc) - Yakuniy foyda|Sof foyda IBIO (iBio Corp)|Sof moliyaviy natija Carisma Therapeutics Inc (CARM)|XTLB - Kompaniyaning sof foydasi|Bolt Biotherapeutics (BOLT) - Sof daromad|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Sof daromad Aptevo Therapeutics Inc.|Sof daromad AIM|Sof foyda Aditxt Corp|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|xortx.com - Kompaniya foydasi|Sof foyda HIND (Vyome Holdings)|Revelation Biosciences Inc (REVB) - Kompaniyaning sof daromadi|Indaptus - Sof foyda|Sof moliyaviy natija BiondVax Pharmaceuticals SCNI|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Sof daromad IGMS (IGM Biosciences, Inc.)|Sof foyda iTeos Pharma (ITOS)|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP: Kompaniya foydasi|THRD - Kompaniyaning sof foydasi